Publication

Semi-Automated Volumetric and Morphological Assessment of Glioblastoma Resection with Fluorescence-Guided Surgery

Downloadable Content

Persistent URL
Last modified
  • 02/20/2025
Type of Material
Authors
    J. Scott Cordova, Emory UniversitySaumya S. Gurbani, Emory UniversityChad Holder, Emory UniversityJeffrey Olson, Emory UniversityEduard Schreibmann, Emory UniversityRan Shi, Emory UniversityYing Guo, Emory UniversityHui-Kuo Shu, Emory UniversityHyunsuk Shim, Emory UniversityConstantinos Hadjipanayis, Emory University
Language
  • English
Date
  • 2015-10-13
Publisher
  • Springer Verlag (Germany)
Publication Version
Copyright Statement
  • © 2015 World Molecular Imaging Society.
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1536-1632
Volume
  • 18
Issue
  • 3
Start Page
  • 454
End Page
  • 462
Grant/Funding Information
  • This work was supported by National Institute of Health grants R21 CA141836 (CGH/CAH/HS), a predoctoral fellowship F31 CA180319 (JSC), and a research grant from Nx Development Corp. (CGH).
Supplemental Material (URL)
Abstract
  • Purpose: Glioblastoma (GBM) neurosurgical resection relies on contrast-enhanced MRI-based neuronavigation. However, it is well-known that infiltrating tumor extends beyond contrast enhancement. Fluorescence-guided surgery (FGS) using 5-aminolevulinic acid (5-ALA) was evaluated to improve extent of resection (EOR) of GBMs. Preoperative morphological tumor metrics were also assessed. Procedures: Thirty patients from a phase II trial evaluating 5-ALA FGS in newly diagnosed GBM were assessed. Tumors were segmented preoperatively to assess morphological features as well as postoperatively to evaluate EOR and residual tumor volume (RTV). Results: Median EOR and RTV were 94.3 % and 0.821 cm3, respectively. Preoperative surface area to volume ratio and RTV were significantly associated with overall survival, even when controlling for the known survival confounders. Conclusions: This study supports claims that 5-ALA FGS is helpful at decreasing tumor burden and prolonging survival in GBM. Moreover, morphological indices are shown to impact both resection and patient survival.
Author Notes
  • Corresponding Authors: Costas G. Hadjipanayis, M.D., Ph.D., Department of Neurosurgery, Mount Sinai Beth Israel, Philips Ambulatory Care Center, 10 Union Square, 5th Floor, Suite 5E, New York, NY 10003, Phone: 212-844-6922; Fax: 212-844-6119, constantinos.hadjipanayis [at] mountsinai [dot] org, Hyunsuk Shim, Ph.D., Department of Radiology, Winship Cancer Institute, 1701 Uppergate Drive, C5018, Atlanta, GA 30322, Phone: (404) 778-4564; FAX: (404) 778-5550, hshim [at] emory [dot] edu.
Keywords
Research Categories
  • Health Sciences, Oncology
  • Health Sciences, Medicine and Surgery

Tools

Relations

In Collection:

Items